Delivery Order SPE2DB22D1202-SPE2DB25FVCZ3
Award Date
6/24/25
Potential Completion Date
6/25/25
Potential Value
$44K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $30,812.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a prescription medication, with an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999, for providing a...
This is a $7,248.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, with a performance period ending on May 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The $41,412.32 contract has a completion date of June 23, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through...
This is a $28,189.69 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, with a period of performance through May 30, 2025. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a global pharmaceutical support...
This is a $11,602.50 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of GEMTESA 75 MG TABLET 30S, with a completion date of June 5, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a $13,800.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of July 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $2,672.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of April 10, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,652.12, is for the delivery of 4,568,059,839 units of the medication GEMTESA 75 MG TABLET 90S. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a $39,659.16 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a prescription pharmaceutical product. The period of performance runs from September 10, 2024 through September 11, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a $72,890.30 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides GEMTESA 75 MG TABLET 90S to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...